Know Labs (NYSEAMERICAN:KNW) Trading 3.8% Higher – Here’s What Happened

Know Labs, Inc. (NYSEAMERICAN:KNW)’s stock price rose 3.8% during mid-day trading on Tuesday . The company traded as high as $2.17 and last traded at $2.1390. 612,050 shares were traded during mid-day trading, a decline of 86% from the average session volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Trading Up 3.8%

The company has a market capitalization of $16.04 million, a price-to-earnings ratio of -0.33 and a beta of 1.83. The company’s 50 day simple moving average is $2.14 and its 200-day simple moving average is $2.14.

Institutional Trading of Know Labs

A hedge fund recently bought a new stake in Know Labs stock. Corient Private Wealth LLC bought a new position in Know Labs, Inc. (NYSEAMERICAN:KNW) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 50,000 shares of the company’s stock, valued at approximately $99,000. Corient Private Wealth LLC owned 0.67% of Know Labs as of its most recent filing with the Securities and Exchange Commission. 23.96% of the stock is owned by hedge funds and other institutional investors.

About Know Labs

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.